2-(3-Aryl-2-propenoyl)-3-methylquinoxaline-1,4-dioxides: A novel cluster of tumor-specific cytotoxins which reverse multidrug resistance

The quinoxaline derivatives 3 possess one or more of the following features, namely antiproliferative activities, selective cytotoxicity to neoplasms than normal cells and MDR-revertant properties.